{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:12:23Z","timestamp":1790521943286,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,3,9]],"date-time":"2009-03-09T00:00:00Z","timestamp":1236556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dextropropoxyphene is a weak opioid analgesic, widely used as a step 2 analgesic (according to WHO classification) in combination with peripheral analgesics, mainly paracetamol. Recent data have underlined its poor analgesic efficacy (in comparison with paracetamol), risks of serious adverse drug reactions (i.e. hepatic reactions, hallucinations, abuse, withdrawal symptoms, hypoglycaemia), possible lethality after overdose, its risk of accumulation in patients with renal failure or in elderly people and some pharmacokinetic insufficiencies (i.e. different half\u2010lives for dextropropoxyphene and paracetamol). Taking into account these data, the drug committee of the Toulouse University Hospital (France) decided to withdraw dextropropoxyphene from the hospital formulary since 1 June 2005. The aim of our study was to investigate the consequences of this withdrawal by comparing use of analgesic drugs in Toulouse University Hospital before (2004) and after (2006) dextropropoxyphene withdrawal (using defined daily dose for 1000 hospitalization\u2010days as the unit measure). Before withdrawal, dextropropoxyphene (in combination with paracetamol) was the second most used analgesic drug after paracetamol alone. After dextropropoxyphene withdrawal, total consumption of analgesic drugs decreased by 4.6% (2006 vs. 2004). There was a 28% decrease in consumption of step 2 analgesics [with an increase in oral tramadol and a slight decrease in codeine (in combination with paracetamol)]. During the same period, step 1 analgesic consumption increased by 11% (mainly paracetamol) and that of step 3 analgesics slightly decreased (\u22128%). These results show that dextropropoxyphene withdrawal was not associated with a marked switch in prescriptions towards other analgesic drugs. This paper underlines the interest of a hospital\u2010based drug committee to promote rational drug use. Finally, the present data allow us to discuss putative misuse of dextropropoxyphene.<\/jats:p>","DOI":"10.1111\/j.1472-8206.2008.00661.x","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T01:51:01Z","timestamp":1236649861000},"page":"247-252","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption"],"prefix":"10.1111","volume":"23","author":[{"given":"Sabine","family":"Gaubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Vi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Damase\u2010Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,18]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"547","volume-title":"Goodman and Gilman\u2019s, The Pharmacological Basis of Therapeutics","author":"Gutstein H.B.","year":"2001"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7122.1565"},{"key":"e_1_2_6_4_2","article-title":"Single dose dextropropoxyphene, alone and with paracetamol (acetaminophen) for postoperative pain","volume":"2","author":"Collins S.L.","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02252.x"},{"key":"e_1_2_6_6_2","first-page":"20","article-title":"Dextropropoxyphene combinations: Swedish market withdrawal","volume":"15","author":"Prescrire R\u00e9daction","year":"2006","journal-title":"Prescrire Int."},{"key":"e_1_2_6_7_2","unstructured":"Medicines and Health Care Products Regulatory Agency.Withdrawal of co\u2010proxamol. Available at:http:\/\/www.mhra.gov.uk\/mhra\/CurrentProblemsInPharmacovigilance; last accessed on 16 June 2008."},{"key":"e_1_2_6_8_2","volume-title":"Martindale: The Complete Drug Reference","author":"Dextropropoxyphene","year":"2007"},{"key":"e_1_2_6_9_2","unstructured":"World Health Organisation.WHO\u2019s Pain Relief Ladder. Available at:http:\/\/www.who.int\/cancer\/palliative\/painladder\/en\/; last accessed on 2 June 2008."},{"key":"e_1_2_6_10_2","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.ATC\/DDD Index. Available at:http:\/\/www.who.no\/atcddd\/; last accessed 2 June 2008."},{"key":"e_1_2_6_11_2","first-page":"433","article-title":"Formularies: the role of pharmacy\u2010and\u2010therapeutics (P&T) committees","volume":"15","author":"Summers K.H.","year":"1993","journal-title":"Clin. Ther."},{"key":"e_1_2_6_12_2","unstructured":"Compte\u2010rendu du Comit\u00e9 Antalgiques du 13\u2003F\u00e9vrier.2006 Comit\u00e9 du M\u00e9dicament du CHU de Toulouse 22 May 2006."},{"key":"e_1_2_6_13_2","unstructured":"Comit\u00e9 de lutte contre la douleur du CHU de Toulouse.Proc\u00e9dure d\u2019utilisation du patch de fentanyl Durog\u00e9sic\u00ae CLUD06. Available at:http:\/\/www.chu\u2010toulouse.fr\/IMG\/pdf\/DUROGESIC_version_pour_intranet.pdf.; last accessed on 2 June 2008"},{"key":"e_1_2_6_14_2","volume-title":"Cancer Pain Relief: With a Guide to Opioid Availability","author":"World Health Organisation","year":"1996"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2630040610"},{"key":"e_1_2_6_16_2","unstructured":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9.Les ventes de m\u00e9dicaments aux officines et aux h\u00f4pitaux en France \u2013 Chiffres\u2010cl\u00e9s.2005. Available at:http:\/\/afssaps.sante.fr\/htm\/5\/rapport_vente_medicament_chiffre_2005.htm; last accessed 12 March 2008."},{"key":"e_1_2_6_17_2","first-page":"549","article-title":"Evaluation du coulage m\u00e9dicamenteux en distribution globale","volume":"418","author":"Edouard B.","year":"2002","journal-title":"Gest. Hosp."},{"key":"e_1_2_6_18_2","first-page":"1007","article-title":"Pilferage of controlled substances in hospitals","volume":"38","author":"Hoover R.C.","year":"1981","journal-title":"Am. J. Hosp. Pharm."},{"key":"e_1_2_6_19_2","first-page":"1057","article-title":"Guidelines for the prevention and detection of controlled substance diversion","volume":"23","author":"Carlson G.M.","year":"1988","journal-title":"Hosp. Pharm."},{"key":"e_1_2_6_20_2","unstructured":"Direction de l'Hospitalisation et de l'Organisation des Soins.Circulaire DHOS\/E2\/2002\/266 du 30 Avril 2002. Available at:http:\/\/www.sante.gouv.fr\/htm\/dossiers\/prog_douleur\/doc_pdf\/circ020430.pdf."}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2008.00661.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.2008.00661.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T02:54:54Z","timestamp":1697338494000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2008.00661.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,18]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1472-8206.2008.00661.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2008.00661.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,18]]},"assertion":[{"value":"2009-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}